Using biomaterials to boost T cell immunity against cancer
Biomaterials to Create T Cell Immunity
This study is exploring new ways to boost the immune system's T cells, which help fight cancer, by using special materials to create artificial cells that can better activate them, with the hope of developing improved treatments for cancer patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Harvard University NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project ID | NIH-9870084 on NIH RePORTER |
What this research studies
This research focuses on enhancing the immune response of T cells, which are crucial for fighting cancer, by utilizing innovative biomaterials. The approach involves creating artificial antigen-presenting cells that can effectively activate T cells, leading to a stronger anti-cancer response. By collaborating with experts in bioengineering and cancer immunology, the project aims to develop new therapies that can improve T cell function and increase their numbers. Patients may benefit from these advancements through more effective cancer immunotherapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with cancer who may benefit from enhanced T cell responses.
Not a fit: Patients with non-cancerous conditions or those who do not have a functional immune system may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer treatments that harness the body's immune system to fight tumors.
How similar studies have performed: Previous research has shown promise in using biomaterials for immunotherapy, indicating that this approach could lead to significant advancements in cancer treatment.
Where this research is happening
Cambridge, United States
- Harvard University — Cambridge, United States (Active)
Researchers
- Principal investigator: Mooney, David J — Harvard University
- Study coordinator: Mooney, David J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.